Roth MKM keeps a Buy rating and $16 price target on Allurion Technologies (ALUR) after its initial results from Allurion Program-GLP-1 combo.
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Allurion Technologies (ALUR – Research Report) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback